全文获取类型
收费全文 | 3173篇 |
免费 | 289篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 75篇 |
妇产科学 | 43篇 |
基础医学 | 531篇 |
口腔科学 | 67篇 |
临床医学 | 451篇 |
内科学 | 578篇 |
皮肤病学 | 30篇 |
神经病学 | 307篇 |
特种医学 | 112篇 |
外科学 | 460篇 |
综合类 | 55篇 |
一般理论 | 4篇 |
预防医学 | 214篇 |
眼科学 | 183篇 |
药学 | 204篇 |
中国医学 | 2篇 |
肿瘤学 | 129篇 |
出版年
2023年 | 34篇 |
2022年 | 49篇 |
2021年 | 135篇 |
2020年 | 69篇 |
2019年 | 84篇 |
2018年 | 103篇 |
2017年 | 82篇 |
2016年 | 90篇 |
2015年 | 92篇 |
2014年 | 133篇 |
2013年 | 163篇 |
2012年 | 249篇 |
2011年 | 250篇 |
2010年 | 126篇 |
2009年 | 100篇 |
2008年 | 163篇 |
2007年 | 187篇 |
2006年 | 129篇 |
2005年 | 133篇 |
2004年 | 105篇 |
2003年 | 88篇 |
2002年 | 88篇 |
2001年 | 66篇 |
2000年 | 65篇 |
1999年 | 72篇 |
1998年 | 35篇 |
1997年 | 29篇 |
1996年 | 23篇 |
1995年 | 25篇 |
1994年 | 13篇 |
1993年 | 11篇 |
1992年 | 42篇 |
1991年 | 40篇 |
1990年 | 33篇 |
1989年 | 49篇 |
1988年 | 38篇 |
1987年 | 28篇 |
1986年 | 27篇 |
1985年 | 21篇 |
1984年 | 23篇 |
1983年 | 14篇 |
1979年 | 10篇 |
1978年 | 17篇 |
1977年 | 11篇 |
1975年 | 8篇 |
1974年 | 10篇 |
1973年 | 12篇 |
1969年 | 11篇 |
1968年 | 8篇 |
1965年 | 9篇 |
排序方式: 共有3474条查询结果,搜索用时 15 毫秒
91.
Sansbury FH Flanagan SE Houghton JA Shuixian Shen FL Al-Senani AM Habeb AM Abdullah M Kariminejad A Ellard S Hattersley AT 《Diabetologia》2012,55(9):2381-2385
Aims
The gene SLC2A2 encodes GLUT2, which is found predominantly in pancreas, liver, kidney and intestine. In mice, GLUT2 is the major glucose transporter into pancreatic beta cells, and biallelic Slc2a2 inactivation causes lethal neonatal diabetes. The role of GLUT2 in human beta cells is controversial, and biallelic SLC2A2 mutations cause Fanconi–Bickel syndrome (FBS), with diabetes rarely reported. We investigated the potential role of GLUT2 in the neonatal period by testing whether SLC2A2 mutations can present with neonatal diabetes before the clinical features of FBS appear. 相似文献92.
Passman RS Bennett CL Purpura JM Kapur R Johnson LN Raisch DW West DP Edwards BJ Belknap SM Liebling DB Fisher MJ Samaras AT Jones LG Tulas KM McKoy JM 《The American journal of medicine》2012,125(5):447-453
Although amiodarone is the most commonly prescribed anti-arrhythmic drug, its use is limited by serious toxicities, including optic neuropathy. Current reports of amiodarone-associated optic neuropathy identified from the Food and Drug Administration's Adverse Event Reporting System and published case reports were reviewed. A total of 296 reports were identified: 214 from the Adverse Event Reporting System, 59 from published case reports, and 23 from adverse events reports for patients enrolled in clinical trials. Mean duration of amiodarone therapy before vision loss was 9 months (range 1-84 months). Insidious onset of amiodarone-associated optic neuropathy (44%) was the most common presentation, and nearly one third were asymptomatic. Optic disk edema was present in 85% of cases. Following drug cessation, 58% had improved visual acuity, 21% were unchanged, and 21% had further decreased visual acuity. Legal blindness (<20/200) was noted in at least one eye in 20% of cases. Close ophthalmologic surveillance of patients during the tenure of amiodarone administration is warranted. 相似文献
93.
94.
Meng F Francis H Glaser S Han Y DeMorrow S Stokes A Staloch D Venter J White M Ueno Y Reid LM Alpini G 《Hepatology (Baltimore, Md.)》2012,55(1):209-221
Functional pluripotent characteristics have been observed in specific subpopulations of hepatic cells that express some of the known cholangiocyte markers. Although evidence indicates that specific cytokines, granulocyte macrophage colony-stimulating factors (GM-CSFs), and stem cell factors (SCFs) may be candidate treatments for liver injury, the role of these cytokines in intrahepatic biliary epithelium remodeling is unknown. Thus, our aim was to characterize the specific cytokines that regulate the remodeling potentials of cholangiocytes after 70% partial hepatectomy (PH). The expression of the cytokines and their downstream signaling molecules was studied in rats after 70% PH by immunoblotting and in small and large murine cholangiocyte cultures (SMCCs and LMCCs) by immunocytochemistry and real-time polymerase chain reaction (PCR). There was a significant, stable increase in SCF and GM-CSF levels until 7 days after PH. Real-time PCR analysis revealed significant increases of key remodeling molecules, such as S100 calcium-binding protein A4 (S100A4) and miR-181b, after SCF plus GM-CSF administration in SMCCs. SMCCs produced significant amounts of soluble and bound SCFs and GM-CSFs in response to transforming growth factor-beta (TGF-β). When SMCCs were incubated with TGF-β plus anti-SCF+GM-CSF antibodies, there was a significant decrease in S100A4 expression. Furthermore, treatment of SMCCs with SCF+GM-CSF significantly increased matrix metalloproteinases (MMP-2 and MMP-9) messenger RNA as well as miR-181b expression, along with a reduction of metalloproteinase inhibitor 3. Levels of MMP-2, MMP-9, and miR-181b were also up-regulated in rat liver and isolated cholangiocytes after PH. CONCLUSION: Our data suggest that altered expression of SCF+GM-CSF after PH can contribute to biliary remodeling (e.g., post-transplantation) by functional deregulation of the activity of key signaling intermediates involved in cell expansion and multipotent differentiation. 相似文献
95.
Roger O. Gervais Ph.D Yossef S. Ben-Porath Dustin B. Wygant Paul Green 《The Clinical neuropsychologist》2013,27(6):1061-1079
The MMPI-2 Response Bias Scale (RBS) is designed to detect response bias in forensic neuropsychological and disability assessment settings. Validation studies have demonstrated that the scale is sensitive to cognitive response bias as determined by failure on the Word Memory Test (WMT) and other symptom validity tests. Exaggerated memory complaints are a common feature of cognitive response bias. The present study was undertaken to determine the extent to which the RBS is sensitive to memory complaints and how it compares in this regard to other MMPI-2 validity scales and indices. This archival study used MMPI-2 and Memory Complaints Inventory (MCI) data from 1550 consecutive non-head-injury disability-related referrals to the first author's private practice. ANOVA results indicated significant increases in memory complaints across increasing RBS score ranges with large effect sizes. Regression analyses indicated that the RBS was a better predictor of the mean memory complaints score than the F, FB, and FP validity scales and the FBS. There was no correlation between the RBS and the CVLT, an objective measure of verbal memory. These findings suggest that elevated scores on the RBS are associated with over-reporting of memory problems, which provides further external validation of the RBS as a sensitive measure of cognitive response bias. Interpretive guidelines for the RBS are provided. 相似文献
96.
97.
98.
Jay R Shapiro Caressa Lietman Monica Grover James T Lu Sandesh CS Nagamani Brian C Dawson Dustin M Baldridge Matthew N Bainbridge Dan H Cohn Maria Blazo Timothy T Roberts Feng‐Shu Brennen Yimei Wu Richard A Gibbs Pamela Melvin Philippe M Campeau Brendan H Lee 《Journal of bone and mineral research》2013,28(7):1523-1530
99.
Miriam E. Delphin-Rittmon Raquel Andres-Hyman Elizabeth H. Flanagan Larry Davidson 《The Psychiatric quarterly》2013,84(1):53-64
Racial and ethnic disparities are disturbing facets of the American healthcare system that document the reality of unequal treatment. Research consistently shows that patients of color experience poorer quality of care and health outcomes contributing to increased risks and accelerated mortality rates relative to their white counterparts. While initially conceptualized as an approach for increasing the responsiveness of children’s behavioral health care, cultural competence has been adopted as a key strategy for eliminating racial and ethnic health disparities across the healthcare system. However, cultural competence research and practices largely focus on improving provider competencies, while agency and system level approaches for meeting the service needs of diverse populations are given less attention. In this article we offer seven essential strategies for promoting and sustaining organizational and systemic cultural competence. These strategies are to: (1) Provide executive level support and accountability, (2) Foster patient, community and stakeholder participation and partnerships, (3) Conduct organizational cultural competence assessments, (4) Develop incremental and realistic cultural competence action plans, (5) Ensure linguistic competence, (6) Diversify, develop, and retain a culturally competent workforce, and (7) Develop an agency or system strategy for managing staff and patient grievances. For each strategy we offer several recommendations for implementation. 相似文献
100.
Dustin K Ragan Robert McKinstry Tammie Benzinger Jeffrey R Leonard Jose A Pineda 《Journal of cerebral blood flow and metabolism》2013,33(1):48-52
Traumatic brain injury (TBI) is the most common cause of acquired disability in children. Metabolic defects, and in particular mitochondrial dysfunction, are important contributors to brain injury after TBI. Studies of metabolic dysfunction are limited, but magnetic resonance methods suitable for use in children are overcoming this limitation. We performed noninvasive measurements of cerebral blood flow and oxygen metabolic index (OMI) to assess metabolic dysfunction in children with severe TBI. Cerebral blood flow is variable after TBI but hypoperfusion and low OMI are predominant, supporting metabolic dysfunction. This finding is consistent with preclinical and adult clinical studies of brain metabolism and mitochondrial dysfunction after TBI. 相似文献